Stem Cell Congress offers new hope to cancer, diabetes patients

The Dubai Stem Cell Congress, held in Dubai over two days, concluded with valuable scientific discussions and significant attendance from global physicians and specialists. The conference sessions focused on the latest treatments in regenerative medicine and the impact of scientific research on stem cells in developing treatment techniques for various diseases such as cancer, thalassemia, and diabetes. Additionally, the congress showcased the inspiring recovery journeys of patients who had been given new hope through stem cell therapy.

The Dubai Stem Cell Congress held special significance as it aimed to offer a potential cure for all diseases in the future.

This year, the congress aimed to elevate the level of scientific sessions by attracting 30 international speakers in the stem cell sector, including 18 speakers from the United States. This diverse exchange of ideas and innovations was led by key figures like Dr Essam Abdelalim, Principal Investigator at Sidra

Medicine. His work on pluripotent stem cells focused on understanding the basic physiology needed to develop diabetes and produce functional pancreatic cells for potential use in cell therapy.

During the main session, in-depth discussions delved into the biological and genetic mechanisms underlying stem cells, aiming to comprehend their developmental processes and explore enhanced therapeutic approaches for managing diabetes.

The Dubai Stem Cell Congress held special significance as it aimed to offer a potential cure for all diseases in the future